# Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)

Study · id `cardio:ct-nct05172765` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05172765](<https://clinicaltrials.gov/study/NCT05172765>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05172765

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.

## Technical summary

Registry record NCT05172765. Randomized; double masking; primary purpose treatment. Start 2022-09-14 (actual); primary completion 2025-10-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 160 participants (planned count; ClinicalTrials.gov record NCT05172765, source copy `cardio:ctgov-nct05172765-2024-03-06`, retrieved 2026-10-26)
- Started: 2022-09-14 (actual) (ClinicalTrials.gov record NCT05172765, source copy `cardio:ctgov-nct05172765-2024-03-06`, retrieved 2026-10-26)
- Primary completion: 2025-10-31 (anticipated) (ClinicalTrials.gov record NCT05172765, source copy `cardio:ctgov-nct05172765-2024-03-06`, retrieved 2026-10-26)
- Completion: 2026-05-29 (anticipated) (ClinicalTrials.gov record NCT05172765, source copy `cardio:ctgov-nct05172765-2024-03-06`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05172765, source copy `cardio:ctgov-nct05172765-2024-03-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05172765-2024-03-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)
- Condition: Paroxysmal Atrial Fibrillation
- Intervention (Device): Transcutaneous Electrical Nerve Stimulation Device
- Lead sponsor: University of Oklahoma
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: University of Oklahoma (`cardio:org-university-of-oklahoma`)

## Provenance

Content hash: 85a20afd911a84d0fc16465759f0693fd2d3112c2572181c15f2e4d606de2619
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
